Last $66.19 USD
Change Today +1.24 / 1.91%
Volume 6.3M
MDT On Other Exchanges
Symbol
Exchange
New York
Mexico
Frankfurt
As of 8:04 PM 09/16/14 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

710 Medtronic Parkway

Minneapolis, MN 55432

United States

Phone: 763-514-4000

Fax:

which includes the AdaptivCRT software. In the U.S., the company’s new CRT-P devices are Consulta and Syncra. AF Products: The company’s portfolio of AF products includes the Arctic Front Advance Cardiac Cryoballoon System designed for pulmonary vein isolation in the treatment of patients with drug refractory paroxysmal AF. Additionally, it has a second-generation CE Mark approved Phased RF System, PVAC Gold, which uses duty cycled, phased radio frequency energy for the treatment of symptomatic paroxysmal persistent and long-standing persistent AF. The company’s Phased RF portfolio, including PVAC Gold, is being clinically evaluated by the U.S. FDA. Diagnostics and Monitoring Devices: The Reveal LINQ is the company’s newest Insertable Cardiac Monitor (ICM) System having received the U.S. FDA and CE Mark approval. The system is used to record the heart’s electrical activity before, during, and after transient symptoms, such as syncope (fainting) and palpitations to help provide a diagnosis and is the smallest ICM device available for patients. Services and Solutions: The company is expanding its medical device product offerings to include health care services and solutions that provide meaningful clinical outcomes and economic value for hospitals, physicians, patients, and payers. Such services and solutions include various platforms. The company’s Cardiocom products and services include remote monitoring and patient-centered software to enable care coordination and specialized telehealth nurse support. Its TYRX products include the U.S. FDA cleared AIGISRx R fully resorbable antibacterial envelope and AIGISRx N antibacterial envelope, which are designed to reduce surgical site infections associated with implantable pacemakers, defibrillators, and spinal cord neurostimulators. The company’s Cath Lab Managed Services business is focused on developing novel partnerships with hospitals to provide services directly related to hospital operational efficiency. The business is initially focused on offering services in Europe to manage and modernize catheterization lab (cath lab) facilities. Patient Management Tools: The company has various patient management tools, such as Patient Home Monitors, CareLink Express, Paceart, and CardioSight Service. Customers: The primary medical specialists who use the company’s CRDM products include electrophysiologists, implanting cardiologists, heart failure specialists, and cardiovascular surgeons. Competition: The company’s primary competitors in the CRDM business are St. Jude Medical, Inc. (St. Jude); Boston Scientific Corporation (Boston Scientific); Biotronik, Inc.; and Sorin Group (Sorin). Coronary Coronary includes therapies to treat coronary artery disease (CAD) and hypertension. The products contained within this business include coronary stents and related delivery systems, including a line of balloon angioplasty catheters, guide catheters, guidewires, diagnostic catheters, and accessories. The following are the principal products offered by the company’s Coronary business: Percutaneous Coronary Intervention (PCI): PCI includes various procedures used to treat patients with CAD. The company’s PCI stent products include its resolute integrity, resolute, and endeavor drug-eluting stent systems, as well as its integrity, driver, and micro-driver bare metal stent systems. Customers: The primary medical specialists who use the company’s Coronary products are interventional cardiologists. Competition: The company’s primary competitors in the Coronary business are Abbott Laboratories (Abbott) and Boston Scientific. Structural Heart The Structural Heart business offers a line of products and therapies to treat various heart valve disorders. The company’s products include products for the repair and replacement of heart valves, perfusion systems, positioning and stabilization systems for beating heart revascularization surgery, and surgical ablation products. The following are the principal products offered by the company’s Structural Heart business: Transcatheter Heart Valves (TCVs): TCV technology represents a less invasive means to treat heart valve

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MDT:US $66.19 USD +1.24

MDT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abbott Laboratories $42.90 USD +0.18
Allergan Inc/United States $170.20 USD +1.64
Astellas Pharma Inc ¥1,584 JPY -6.50
Becton Dickinson and Co $114.29 USD +0.23
Covidien PLC $91.66 USD +1.19
View Industry Companies
 

Industry Analysis

MDT

Industry Average

Valuation MDT Industry Range
Price/Earnings 22.0x
Price/Sales 3.8x
Price/Book 3.3x
Price/Cash Flow 19.1x
TEV/Sales 2.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDTRONIC INC, please visit www.medtronic.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.